Did you miss out on this year's BioProcess International conference? You can still access key insights, use the #AAV #Bioprocessing Workflow Optimization Calculator, and see the poster through our website! If you're here with us, visit booth 413! for an interactive experience! Discover new #transfection solutions, run your own #reagent comparison, and dive into a case study. https://lnkd.in/eWyuDvFh #GeneTherapy #BPIconf #BPI2024
Mirus Bio
Biotechnology Research
Madison, WI 4,462 followers
The Transfection Experts
About us
OUR MISSION: Deliver Innovation. Empower Discovery. Improve Life. For over 25 years, Mirus Bio has pioneered the development of transfection reagents and proprietary technologies for nucleic acid delivery applications. Our work is both technical and cutting-edge, and we promote a culture of creativity, responsibility, and respect. Our team members are engaged and motivated by the desire to support our customers and partners to achieve strong results. Mirus, together with Gamma Biosciences, is establishing the future of science and medicine by developing products that enable product developers within the cell and gene therapy space. As we approach a new era of addressing and conquering life-altering diseases, we will continue to expand our expertise and leadership in transfection to be integral in the future of advanced therapies.
- Website
-
http://www.mirusbio.com
External link for Mirus Bio
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Madison, WI
- Type
- Public Company
- Founded
- 1994
Locations
-
Primary
5602 Research Park Blvd
Ste 210
Madison, WI 53719, US
Employees at Mirus Bio
-
Geoffrey Schwartz
Life Science Executive
-
Dale Gordon
CEO | Healthcare, Life Sciences, Bioprocess, Cell and Gene Therapy, Diagnostics, and Laboratory Tools
-
Nathan Stehle
R&D Chemist/GMP/Discovery/Research/Development/Manufacturing/Purification/Safety
-
Fletcher Malcom
Strategy, Product and Business Development at Mirus
Updates
-
We're underway at BioProcess International at #BostonBiotechWeek #Transfection affects everything; Boost productivity in your #GeneTherapy pipeline by chatting with transfection experts this week. Find us near MilliporeSigma (booths 413 and 419, respectively) to learn about the next-generation #transfection solutions that are available to #upstream process developers. Explore tools, posters, products, and info here: https://lnkd.in/eWyuDvFh #CGT #BPIconf #bioprocessing #viralvector #processdevelopment #biomanufacturing
-
What are you hoping to get out of #BiotechWeekBoston? Upstream process developers interested in the newest upstream innovations should stop by booth 413 (or poster no. 87) at BioProcess International to see how they can most efficiently scale from benchtop to #bioreactor. - Learn more about the RevIT GMP AAV titer enhancer - Access the next generation of transfection solutions - Explore tools and tips to see if you could be saving millions Find us at booth 413 next to the MilliporeSigma booth and be sure to stop by both booths to explore all upstream process solutions. Come see poster 87 during breaks, lunch, and the poster receptions, where our very own Leisha Kopp will be presenting and answering questions! We can't wait to see you! #BPIconf #BioProcessing #GeneTherapy
-
What are you hoping to get out of #BiotechWeekBoston? Upstream process developers interested in the newest upstream innovations should stop by booth 413 (or our poster) at BioProcess International to see how they can most efficiently scale from benchtop to #bioreactor. - Learn more about the RevIT GMP AAV titer enhancer - Access the next generation of transfection solutions - Explore tools and tips to see if you could be saving millions Find us at booth 413 next to the MilliporeSigma booth and be sure to stop by both booths to explore all upstream process solutions. We can't wait to see you! #BPIconf #BioProcessing #GeneTherapy
-
Mirus Bio reposted this
#Webinar now available on demand! Short and long-term impacts of #AAV process optimization on #genetherapy pipelines High yield, high quality, and high-efficiency #AAVproduction is essential for advancing gene therapy. However, producing enough viral particles in a cost-effective way for moderate to large prevalence diseases poses significant challenges. In this webinar, Fletcher Malcom (Director of Strategy Product and Business Development, Mirus Bio) explores upstream process optimization strategies to enhance AAV production efficiency and support gene therapy advancements. Watch at your convenience below:
-
Mirus Bio reposted this
Great first day with the Astrea Bioseparations and Mirus Bio team at IMAPAC Cell and Gene Therapy Congress in Singapore showcasing our latest and greatest in viral vector production and purification. Looking forward to day 2 (after enjoying sampling some of Singapore delights 🍻)
-
Is your current #AAV manufacturing process delivering the best value? As demand for #GeneTherapies increases, so do the stakes in manufacturing. Even small inefficiencies in your #transfection workflow can significantly drive up the cost per dose, potentially costing your organization millions over the life of a drug asset. Our AAV Economic Calculator is designed to help #bioprocess development scientists and manufacturers optimize their workflows. By comparing different #TransfectionReagents you can identify potential cost savings and ensure you’re not leaving money on the table... or bench. Run your own analysis with the AAV Economic Calculator to see if you could be saving millions! #Therapeutics https://lnkd.in/eAA89MNq
-
Attention #GeneTherapy innovators! Join us tomorrow for a live webinar on optimizing #AAV production. Fletcher Malcom has been optimizing processes for over a decade and will share what top #Biotechs and CDMOs are doing to optimize their #upstream and #downstream processing. Gain access to our AAV Economics Optimization Calculator to compare reagents and learn about cost-effective solutions for your gene therapy pipeline. Don't miss this opportunity to enhance your processes and save costs. Register today: https://lnkd.in/eUfkiKr9 #CGT #CDMO #Transfection (Thank you to Cell & Gene Therapy Insights for hosting!)
-
Mirus Bio reposted this
We are thrilled to announce today the completion of our acquisition of Mirus Bio. This exciting milestone builds on our strong foundation of viral vector manufacturing products and will further enable us to provide differentiated offerings to meet the growing demand for cell and gene therapies. This acquisition will support the industry in advancing cell and gene therapies from preclinical to commercial production, expediting the delivery of life-changing treatments to patients. A big welcome to our new colleagues from Mirus Bio – we cannot wait to learn from and collaborate with you! Read more about the announcement here: http://ms.spr.ly/6044leJmM
-
Mirus Bio reposted this
We are thrilled to announce today the completion of our acquisition of Mirus Bio. This exciting milestone builds on our strong foundation of viral vector manufacturing products and will further enable us to provide differentiated offerings to meet the growing demand for cell and gene therapies. This acquisition will support the industry in advancing cell and gene therapies from preclinical to commercial production, expediting the delivery of life-changing treatments to patients. A big welcome to our new colleagues from Mirus Bio – we cannot wait to learn from and collaborate with you! Read more about the announcement here: http://ms.spr.ly/6042leJmp